Christoph E Hagemeyer Selected Research

Carotid Artery Thrombosis

1/2018	Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging.
3/2014	Detection of activated platelets in a mouse model of carotid artery thrombosis with 18 F-labeled single-chain antibodies.
3/2011	Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibody.
5/2007	Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph E Hagemeyer Research Topics

Disease

21	Thrombosis (Thrombus) 01/2022 - 07/2006
7	Hemorrhage 01/2022 - 07/2006
5	Atherosclerosis 04/2020 - 07/2009
4	Inflammation (Inflammations) 09/2019 - 06/2009
4	Ischemia 01/2018 - 09/2011
4	Carotid Artery Thrombosis 01/2018 - 05/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 07/2017
3	Neoplasms (Cancer) 01/2019 - 01/2015
3	Myocardial Infarction 10/2017 - 01/2010
2	Stroke (Strokes) 04/2022 - 07/2020
2	Ischemic Stroke 04/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Atherosclerotic Plaque (Atheroma) 05/2011 - 07/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022
1	Cicatrix (Scar) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thrombotic Thrombocytopenic Purpura 01/2022
1	Diabetes Mellitus 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Insulin Resistance 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Vascular System Injuries 01/2019
1	Vascular Diseases (Vascular Disease) 01/2018
1	Venous Thromboembolism 01/2018
1	Infarction (Infarctions) 10/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2017
1	Necrosis 12/2016
1	Chest Pain (Chest Pains) 12/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2016
1	Pulmonary Embolism 01/2016
1	Edema (Dropsy) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

6	ferric chlorideIBA 01/2016 - 07/2006
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2022 - 03/2007
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2022 - 06/2012
4	Glycoproteins (Glycoprotein)IBA 01/2018 - 06/2012
3	Plasminogen Activators (Plasminogen Activator)IBA 04/2022 - 09/2015
3	von Willebrand FactorIBA 01/2022 - 01/2019
3	Biological ProductsIBA 04/2020 - 07/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2011
3	LigandsIBA 01/2019 - 01/2010
3	AnticoagulantsIBA 01/2018 - 03/2007
3	Contrast MediaIBA 07/2017 - 05/2011
3	Thrombin FDA Link 01/2016 - 01/2015
3	Single-Chain AntibodiesIBA 03/2014 - 03/2007
2	Pharmaceutical PreparationsIBA 01/2019 - 08/2017
2	EpitopesIBA 03/2011 - 05/2007
2	IntegrinsIBA 01/2010 - 07/2009
2	FibrinIBA 06/2009 - 03/2007
2	Immunoglobulin FragmentsIBA 06/2009 - 03/2007
1	TNK-tissue plasminogen activatorIBA 04/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2022
1	Tenecteplase FDA Link 04/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	caplacizumabIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	GadoliniumIBA 01/2022
1	thiamine triphosphorate (TTP)IBA 01/2022
1	CollagenIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Drinking WaterIBA 01/2021
1	Liposomes (Liposome)IBA 07/2020
1	Molecular Probes (Molecular Probe)IBA 04/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 09/2019
1	aspartylglycineIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Cyclic PeptidesIBA 01/2019
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2017
1	HDL LipoproteinsIBA 10/2017
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2017
1	ProdrugsIBA 08/2017
1	Cisplatin (Platino)FDA LinkGeneric 08/2017
1	AntigensIBA 07/2017
1	ferric oxide (iron oxide)IBA 07/2017
1	Biomarkers (Surrogate Marker)IBA 12/2016
1	Troponin IIBA 12/2016
1	Evans Blue (Blue, Evans)FDA Link 12/2016
1	Fatty Acid Binding Protein 3IBA 12/2016
1	Fatty Acid-Binding ProteinsIBA 12/2016
1	HMGB1 Protein (HMG1)IBA 11/2015
1	Serine Proteases (Serine Protease)IBA 09/2015
1	PolymersIBA 09/2015
1	Platelet Membrane Glycoprotein IIbIBA 09/2015
1	poly(2-oxazoline)IBA 09/2015
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2015
1	ThrombomodulinIBA 01/2015
1	MicellesIBA 01/2015
1	Cell-Free Nucleic AcidsIBA 01/2015

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2010
2	Microbubbles 01/2016 - 06/2012
2	Percutaneous Coronary Intervention 03/2014 - 01/2010
1	Surgical Instruments (Clip) 01/2022
1	Hyperbaric Oxygenation 01/2021
1	Nanospheres 07/2020
1	Intravenous Injections 01/2016
1	Precision Medicine 01/2016
1	Thrombolytic Therapy 01/2016